It's called ibrutinib, and it's a potential breakthrough in treating chronic lymphocytic leukemia (CLL) that could leave patients with fewer side effects than chemotherapy.
Source: http://rss.cnn.com/~r/rss/cnn_health/~3/NbnTPL3puws/index.html
example here as example as an example explained here
No comments:
Post a Comment
Note: only a member of this blog may post a comment.